Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Olivia Berger"'
Autor:
Olivia Berger, PharmD, Katherine Rector, PharmD, BCPS, Jacqueline Meredith, PharmD, BCPS, BCIDP, Jamielynn Sebaaly, PharmD, BCPS
Publikováno v:
Mental Health Clinician, Vol 11, Iss 4, Pp 231-237 (2021)
Introduction: Medications used to treat OUD have common metabolic pathways and pharmacodynamic properties that can lead to drug-drug interactions (DDIs) that may go unnoticed in the inpatient setting. The purpose of this study was to identify the fre
Externí odkaz:
https://doaj.org/article/40fb0477229c4ba1b6da0864fc2f264f
Autor:
Özge Tunçalp, Thae Maung Maung, Ernest Maya, Mamadou Dioulde Balde, Hedieh Mehrtash, Anne-Marie Soumah, Meghan A Bohren, Theresa Azonima Irinyenikan, Nwe Oo Mon, Kwame Adu-Bonsaffoh, Jigyasa Sharma, Hannah Hogan Leslie, Blair Olivia Berger
Publikováno v:
BMJ Global Health, Vol 5, Iss Suppl 2 (2020)
Externí odkaz:
https://doaj.org/article/9daaf5bfa5eb4d64806ef47dfbf63b4e
Publikováno v:
Journal of Pharmacy Practice. 36:74-78
Background: Treatment-dose enoxaparin is not well studied in obese patients. Guidelines suggest that obese patients receiving enoxaparin therapy for acute venous thromboembolism (VTE) should receive a standard initial dose, 1 mg/kg, based on actual b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8938f19aaaabf733a127d783f49a2df0
https://doi.org/10.1177/08971900211022300
https://doi.org/10.1177/08971900211022300
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7773157a1f6bd981e1eca8cc12f58c7c
https://doi.org/10.2139/ssrn.4145111
https://doi.org/10.2139/ssrn.4145111